Align Technology, Inc. Stock

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 16:00:00 2024-06-18 EDT 5-day change 1st Jan Change
242.2 USD -1.35% Intraday chart for Align Technology, Inc. -4.37% -11.61%
Sales 2024 * 4.12B 5.64B Sales 2025 * 4.51B 6.18B Capitalization 18.23B 24.97B
Net income 2024 * 534M 731M Net income 2025 * 648M 887M EV / Sales 2024 * 4.13 x
Net cash position 2024 * 1.2B 1.65B Net cash position 2025 * 1.51B 2.07B EV / Sales 2025 * 3.71 x
P/E ratio 2024 *
34.2 x
P/E ratio 2025 *
28.3 x
Employees 21,670
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.35%
1 week-4.37%
Current month-5.84%
1 month-10.79%
3 months-23.39%
6 months-7.45%
Current year-11.61%
More quotes
1 week
241.89
Extreme 241.89
271.59
1 month
241.89
Extreme 241.89
272.17
Current year
241.89
Extreme 241.89
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 15-05-31
Director of Finance/CFO 57 16-11-09
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 72 06-01-31
Chief Executive Officer 66 15-05-31
Director/Board Member 58 12-04
More insiders
Date Price Change Volume
24-06-18 242.2 -1.35% 885,495
24-06-17 245.5 -4.10% 1,046,171
24-06-14 256 -5.63% 1,078,431
24-06-13 271.3 +1.94% 922,610
24-06-12 266.1 +5.07% 1,032,354

Delayed Quote Nasdaq, June 18, 2024 at 04:00 pm

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
242.2 USD
Average target price
336.6 USD
Spread / Average Target
+38.99%
Consensus